Carl Decicco
2020
In 2020, Carl Decicco earned a total compensation of $1.2M as Former Chief Scientific Officer at Foghorn Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $214,240 |
|---|---|
| Option Awards | $542,224 |
| Salary | $412,000 |
| Other | $50,000 |
| Total | $1,218,464 |
Decicco received $542.2K in option awards, accounting for 45% of the total pay in 2020.
Decicco also received $214.2K in non-equity incentive plan, $412K in salary and $50K in other compensation.
Rankings
In 2020, Carl Decicco's compensation ranked 7,772nd out of 13,090 executives tracked by ExecPay. In other words, Decicco earned more than 40.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,772 out of 13,090 | 41st |
Division Manufacturing | 3,277 out of 5,621 | 42nd |
Major group Chemicals And Allied Products | 1,327 out of 2,254 | 41st |
Industry group Drugs | 1,150 out of 1,954 | 41st |
Industry Pharmaceutical Preparations | 855 out of 1,459 | 41st |
Source: SEC filing on April 29, 2022.
Decicco's colleagues
We found two more compensation records of executives who worked with Carl Decicco at Foghorn Therapeutics in 2020.